Gender issues in the neurobiology of epilepsy: A clinical perspective

Neurobiology of Disease

Volumn 72, Issue PB, 2014, Pages 193-197

  Koppel, Barbara S ^a   Harden, Cynthia L ^b,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c Brain and Spine Specialists   (United States)

Author keywords

Catamenial epilepsy; Epilepsy; Estrogen; Progesterone; Sex hormones; Sexual dysfunction; Testosterone

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CLOBAZAM; DIURETIC AGENT; FINASTERIDE; MEDROXYPROGESTERONE; PROGESTERONE; SEX HORMONE;

ANTICONVULSANT THERAPY; CATAMENIAL EPILEPSY; CLINICAL STUDY; COMPLEX PARTIAL SEIZURE; DISEASE ASSOCIATION; DRUG EFFECT; EPILEPSY; EPILEPTIC DISCHARGE; FEMALE INFERTILITY; HORMONAL REGULATION; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIFESPAN; MALE INFERTILITY; MENSTRUAL IRREGULARITY; MENSTRUATION; NEUROBIOLOGY; PSYCHOLOGICAL ASPECT; PUBERTY; QUALITY OF LIFE; REVIEW; SEIZURE; SEX DIFFERENCE; SEXUAL DYSFUNCTION; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCTION; SEXUAL DEVELOPMENT;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MALE; NEUROBIOLOGY; REPRODUCTION; SEX CHARACTERISTICS;

EID: 84909945954     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.08.033     Document Type: Review

References (54)

1. Akaboshi S., Takeshita K. A case of atypical absence seizures induced by leuprolide acetate. Pediatr. Neurol. 2000, 23:266-268.
2. Alam M.N., Ahmad A., Al-Abbasi F.A., Ahmad A. Female ovarian steroids in epilepsy: a cause or remedy. Pharmacol. Rep. 2013, 65:802-812.
3. Artama M., Isojärvi Raitanen J., Auvinen A. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am. J. Epidemiol. 2004, 159(11):1057-1063.
4. Aydin S., Dag E., Ozkan Y., et al. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol. Cell. Biochem. 2009, 328:49-56.
5. Bäckstrom T., Zetterlund B., Blom S., Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with epilepsy. Acta Neurol. Scand. 1984, 69:240-248.
6. Bäckstrom T., Haage D., Löfgren M., et al. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neurosciences 2011, 191:46-52.
7. Badawy R.A.B., Vogrin S.J., Lai A., Cook M.J. Are patterns of cortical hyperexcitability altered in catamenial epilepsy?. Ann. Neurol. 2013, 74:743-757.
8. Baird A.D., Wilson S.J., Bladin P.F., et al. Sexual outome after epilepsy surgery. Epilepsy Behav. 2003, 4:268-278.
9. Bauer J., Cooper-Mahkorn D. Reproductive dysfunction in women with epilepsy: menstrual cycle abnormalities, fertility and polycystic ovary syndrome. Int. Rev. Neurobiol. 2008, 82:135-155.
10. Dana-Haeri J., Oxley J., Richens A. Pituitary responsiveness to gonadotropin-releasing and thyrotropin-releasing hormones in epileptic patients receiving carbamazepine or phenytoin. Clin. Endocrinol. 1984, 20:163-168.
11. Duncan S., Talbot A., Sheldrick R., Caswell H. Erectile function, sexual desire and psychological well-being in men with epilepsy. Epilepsy Behav. 2009, 15(3):351-357.
12. El-Khayat H.A., Shatla H.M., Ali G.K., et al. Physical and hormonal profile of male sexual development in epilepsy. Epilepsia 2003, 44(3):447-452.
13. Feely M., Calvert R., Gibson J., et al. Clobazam in catamenial epilepsy: A model for evaluating anticonvulsants. Lancet 1982, 2:71-73.
14. Frye C.A. Effects and mechanisms of progestogens and androgens in ictal activity. Epilepsia 2010, 51(Suppl. 3):135-140.
15. Gatti J., Brinker A., Avigan M. Spontaneous reports of seizure in association with leuprolide (lupron depot), goserelin (zoladex implant), and naferelin (synarel nasal spray). Obstet. Gynecol. 2013, 121(5):1107.
16. Gowers W.R. Epilepsy and other chronic convulsive diseases 1881, JA Churchill, London.
17. Grnewald R.A., Aliberti V., Panayiotopoulos C.P. Exacerbation of typical absence seizures by progesterone. Seizure 1992, 1:137-138.
18. Harden C.L., Pulver M.C., Ravdin L., Jacobs A.R. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999, 40(10):1402-1407.
19. Harden C.L., Koppel B.S., Herzog A.G., et al. Seizure frequency is associated with age at menopause in women with epilepsy. Neurology 2003, 61:451-455.
20. Harden C.L., MacLusky N.J. Aromatase inhibitors as add-on treatment for men with epilepsy. Expert. Rev. Neurother. 2005, 5:123-127.
21. Harden C.L., Pennel P.B. Neuroendocrine considerations in the treatment of men and women with epilepsy. Lancet Neurol. 2013, 12:72-83.
22. Herzog A.G., Seibel M.M., Schober D.L., et al. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch. Neurol. 1986, 43:347-350.
23. Herzog A.G., Kleim P., Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 1997, 38:1082-1088.
24. Herzog A.G., Klein P., Jacobs A.R. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 1998, 50:782-784.
25. Herzog A.G., Coleman A.E., Jacobs A.R., et al. Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Ann. Neurol. 2003, 54:625-637.
26. Herzog A.G., Coleman A.E., Jacobs A.R., et al. Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women. Epilepsy Behav. 2003, 4:407-413.
27. Herzog A.G., Frye C.A. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann. Neurol. 2003, 53:390-391.
28. Herzog A.G., Fowler K.M., Sperling M.R., et al. Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia 2011, 52(10):1843-1848.
29. Herzog A.G., Fowler K.M., Smithson S.D., et al. For the progesterone study group. Progesterone vs placebo therapy for women with epilepsy. Neurology 2012, 78:1959-1966.
30. Isojärvi J.I., Löfgren E., Juntunen K.S., et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004, 62(2):247-253.
31. Kaminski R.M., Marini H., Kim W.-J., Rogawski M.A. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 2005, 46(6):819-827.
32. Kuba R., Pohanka M., Zakopcan J., et al. Sexual dysfunctions and blood hormonal profile in men with focal epilepsy. Epilepsia 2006, 47:2135-2140.
33. Lin T.Y., Greenblatt M., Soloman H.C. A polygraphic study of one case of petit mal epilepsy: effects of medication and menstruation. EEG Clin. Neurophysiol. 1952, 4:335-355.
34. Lin S.H., Arai A.C., Espana R.A., et al. Prolactin-releasing peptide (PrRP) promotes awakening and suppresses absence seizures. Neuroscience 2002, 114(1):229-238.
35. Locock C. Discussion of paper by EH Sieveking. Analysis of 52 cases of epilepsy observed by the author. Lancet 1857, 1:527-528.
36. Löfgren E., Pouta A., von Wendt L., et al. Epilepsy in the northern Finland birth cohort 1966 with special reference to fertility. Epilepsy Behav. 2009, 14(1):102-107.
37. Logothetis J., Harner R., Morrell F., Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959, 9:352-360.
38. Mattson R.H., Cramer J.A., Caldwell B.V., et al. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 1984, 34:1255-1258.
39. Milani P., Rocchi R., Cerase A., et al. Heightened seizure susceptibility associated with brain dermoid cyst and the administration of human chorionic gonadotropin (hCG). J. Neurol. Sci. 2007, 258:144-147.
40. Morris G.L., Vanderkolk C. Human sexuality, sex hormones, and epilepsy. Epilepsy Behav. 2005, 7(Suppl. 2):S22-S28.
41. Motta E., Golba A., Ostrowska Z., et al. Progesterone therapy in women with epilepsy. Pharmacol. Rep. 2013, 65:89-98.
42. Murialdo G., Galimberti C.A., Magri F., et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J. Endocrinol. Investig. 1997, 20(9):519-526.
43. Pack A.M. Implications of hormonal and neuroendocrine changes associated with seizures and antiepileptic drugs: a clinical perspective. Epilepsia 2010, 51(Suppl. 3):152-167.
44. Persad V., Wong C.G.T., Cortez M.A., et al. Hormonal regulation of absence seizures. Ann. Neurol. 2004, 55:353-361.
45. Reddy D.S., Rogawski M.A. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009, 6:392-401.
46. Reddy D.S. Role of hormones and neurosteroids in epileptogenesis. Front. Cell. Neurosci. 2013, 7:115.
47. Røste L.S., Tauboll E., Svalheim S., Gjerstad L. Does menopause affect epilepsy?. Seizure 2008, 17:172-175.
48. Sivaraaman K., Mintzer S. Hormonal consequences of epilepsy and its treatment in men. Curr. Opin. Endocrinol. Diabetes Obesity 2011, 18:204-209.
49. Sperling M.R., Pritchard P.B., Engel J., et al. Prolactin in partial epilepsy: an indicator of limbic seizures. Ann. Neurol. 1986, 20:716-722.
50. Velišková J., Desantis K.A. Sex and hormonal influences on seizures and epilepsy. Horm. Behav. 2013, 63(2):267-277.
51. Velišková J., DeJesus G., Kaur R., et al. Females, their estrogens and seizures. Epilepsia 2010, 51(Suppl. 3):141-144.
52. Zelená V., Kuba R., Soška V., Rektor I. Depression as a prominent cause of sexual dysfunction in women with epilepsy. Epilepsy Behav. 2011, 20(3):539-544.
53. Zhou J.Q., Zhou L.M., Chen L.J., et al. Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women. Seizure 2012, 9:729-733.
54. Zimmerman A.W., Holder D.T., Reiter E.O., Dekaban A.S. Medroxyprogesterone acetate in the treatment of seizures associated with menstruation. J. Pediatr. 1973, 83:959-963.